Form 4: ResMed Inc. Executive Michael J. Rider Reports Acquisition of Shares Through Performance-Based Restricted Stock Units

Global General Counsel Michael J. Rider reports acquiring shares of ResMed Inc. through the vesting of performance-based restricted stock units.

Summary

• Michael J. Rider, Global General Counsel of ResMed Inc., filed a Form 4 on August 15, 2024, reporting changes in beneficial ownership of ResMed common stock.
• The report details the acquisition of 4,474 shares and 476 shares of ResMed common stock on August 15, 2024, related to performance-based restricted stock units granted on November 16, 2023.
• The shares were earned when the compensation committee certified that the performance metrics were met.
• Following the reported transactions, Rider beneficially owns 11,394 shares of ResMed common stock directly.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard reporting of stock ownership changes. The vesting of performance-based units suggests positive performance, but the document itself is purely informational.

Positives

• The vesting of performance-based restricted stock units indicates that performance metrics were met, which could be viewed positively.

Future Outlook

The earned units remain subject to time-vesting requirements, and are scheduled to vest on the three-year anniversary of the grant, assuming continued service through the vesting date.

Industry Context

This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies.

Stakeholder Impact

• The change in ownership may have a minor impact on shareholders.

Key Dates